General Insurance Article - WRN partner with Metabiota to expand pandemic risk expertise


The Willis Research Network (WRN) has announced a new partnership with Metabiota, a risk analytics organisation that specialises in infectious diseases modelling and helps businesses and countries build resilience to pandemics.

 The partnership will leverage Metabiota’s epidemiological data analytics capabilities to improve understanding of pandemic risk, build better pandemic risk models, and support mitigation and risk transfer decision making for increased resilience.

 The partnership will also help the global community across both public and private sectors manage the next pandemic in a more broadly informed and pre-planned way once the current crisis has passed its peak. In the private sector, the partnership will help clients improve their structural resilience to pandemics and navigate human resources, insurance business and investment issues more effectively.

 John Haley, CEO, Willis Towers Watson, said: “The research partnership with Metabiota highlights Willis Towers Watson's commitment to developing a full understanding of pandemic risk and providing risk transfer tools to enable communities to build greater resilience to pandemic diseases such as COVID-19. We are focussed on finding innovative ways to apply our risk, capital and people expertise, and with Metabiota we bring a valuable new partner into that mission.”

 Simon Young, senior director, Climate and Resilience Hub, Willis Towers Watson, said: “We are very pleased to welcome Metabiota into the Willis Research Network and look forward to working together through our Climate and Resilience Hub. The SARS-CoV-2 pandemic has shone the brightest of lights on the global need for improved understanding of and preparedness for communicable disease risk, and we plan for our work with Metabiota to encompass innovations around risk understanding tools as well as risk management advisory services and risk transfer solutions.”

 Nita Madhav, CEO of Metabiota, said: “Epidemics and pandemics are very complex risks in terms of how they spark, evolve and impact societies and economies. We’re delighted to collaborate with colleagues across Willis Towers Watson to better understand and quantify the risk posed by pandemics. This partnership recognises the scientific leadership, knowledge and expertise that Metabiota brings to assessing epidemic and pandemic risk, to ultimately protect lives and livelihoods.”
  

Back to Index


Similar News to this Story

Hurricanes and earthquakes could lead to USD300bn losses
Following the long-term annual growth trend of 5–7%, global insured natural catastrophe losses may reach USD 145 billion in 2025, mainly driven by sec
FCA set to launch live AI testing service
The FCA is seeking views from firms about how its live AI testing service can help them to deploy safe and responsible AI, which will benefit UK consu
Over one third of London market firms now actively using AI
The Lloyd’s Market Association (LMA) has hosted a seminar on the use of AI within the London specialty market. The seminar referenced results from a r

Site Search

Exact   Any  

Latest Actuarial Jobs

Actuarial Login

Email
Password
 Jobseeker    Client
Reminder Logon

APA Sponsors

Actuarial Jobs & News Feeds

Jobs RSS News RSS

WikiActuary

Be the first to contribute to our definitive actuarial reference forum. Built by actuaries for actuaries.